Login to Your Account



Trino Raises $12M for Indane Dimers in Ulcerative Colitis

By Cormac Sheridan
Staff Writer

Tuesday, May 28, 2013

DUBLIN, Ireland – Trino Therapeutics Ltd., a spinout from Trinity College Dublin (TCD), raised €9 million (US$11.6 million) in a Series A round to move PH46A, an oral, first-in-class indane dimer, into clinical trials in ulcerative colitis.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription